Products for Research Use Only
RegisterLogin

Gavilimomab

CAT: 0804-HY-P99636Size: InquireDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P99636Size:Inquire
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
CAS Number
244096-20-6
UNSPSC Description
Gavilimomab (ABX-CBL) is an IgM murine monoclonal antibody that recognizes CD147 on the cell surface and initiates cell killing through complement-mediated lysis. Gavilimomab can be used for the research of graft-versus-host disease (GVHD)[1].
Target Antigen
Others
Type
Inhibitory Antibodies
Related Pathways
Others
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/gavilimomab.html
Solubility
H2O
Smiles
[Gavilimomab]
References & Citations
[1]Deeg HJ, et al. Treatment of steroid-refractory acute graft-versus-host disease with anti-CD147 monoclonal antibody ABX-CBL. Blood. 2001 Oct 1;98(7):2052-8.
Shipping Conditions
Room temperature
Clinical Information
Phase 3

Alternative Products

CatalogName
T82331-01Gavilimomab
GTR18333466-01Gavilimomab Antibody
HW664036-01Research Grade Gavilimomab
E55B0398Gavilimomab (Reference antibody)
ICH5568-50mgGavilimomab Biosimilar - Research Grade
GTR18697822-01Gavilimomab Mouse Monoclonal Antibody
A134988Gavilimomab Biosimilar (Monoclonal, IgG1-kappa)
YR1056-01Anti-Human CD147 Recombinant Antibody (Gavilimomab)
PX-TA1076-01Gavilimomab Biosimilar - Anti-BSG, CD147 mAb - Research Grade

Popular Products